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Molecular level, mechanistic understanding of the roles of reactive oxygen species (ROS) in a variety of
pathological conditions is hindered by the difﬁculties associated with determining the concentration of
various ROS species. Here, we present an approach that converts fold-change in the signal from an
intracellular sensor of hydrogen peroxide into changes in absolute concentration. The method uses
extracellular additions of peroxide and an improved biochemical measurement of the gradient between
extracellular and intracellular peroxide concentrations to calibrate the intracellular sensor. By measuring
peroxiredoxin activity, we found that this gradient is 650-fold rather than the 7–10-fold that is widely
cited. The resulting calibration is important for understanding the mass-action kinetics of complex
networks of redox reactions, and it enables meaningful characterization and comparison of outputs from
endogenous peroxide generating tools and therapeutics across studies.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Redox reactions underlie a number of signaling pathways
within cells, causing a variety of observable cellular responses
ranging from homeostasis to proliferation to death [1–4]. Under-
standing the molecular mechanisms that make one of these
responses more likely than another is an active area of research,
and such an understanding has far-reaching practical signiﬁcance
since several pathological states are characterized by altered redox
biology [5]. As one example of a class of pathological states,
cancerous cells are thought to function in the presence of higher
levels of oxidative species than noncancerous cells [6]. Redox
therapeutics are hypothesized to act by causing the intracellular
oxidant level of cancer cells to rise above the upper limit that is
compatible with survival [7–9]. For safety, it is important that the
perturbation induced by the therapeutic stays within the limits of
the defense networks of healthy cells [10]. This hypothesis and
approach are inherently quantitative and success would depend
on the magnitudes of the changes to oxidant levels in healthy and
diseased cells and how the ﬁnal levels relate to the threshold for
survival. However, facile measurement of perturbations to the
intracellular levels of oxidants in terms of concentration and as a
function of time has been a long-standing challenge in the ﬁeld.B.V. This is an open access article uHydrogen peroxide is a particularly interesting oxidant because
of its stability; its longer lifetime allows it to participate either as a
secondary messenger molecule or a lethal oxidant [11]. Most
phenotypic and signaling studies of cellular responses to peroxide
are done using extracellular addition, either with a bolus or with
sustained generation using glucose oxidase [12,13]. However,
hydrogen peroxide has limited permeability across the plasma
membrane [14]. When peroxide is added to the outside of cells,
fast consumption by antioxidant enzymes inside the cell creates a
gradient across the plasma membrane, making the intracellular
concentration lower than the extracellular concentration. Antunes
et al. were the ﬁrst to move from simply reporting external
concentrations to estimating intracellular concentrations by build-
ing a compartmental model that estimates the gradient using
experimentally determined kinetics of known antioxidants and of
the hydrogen peroxide adsorption rate across the membrane [15].
A gradient of 7- to 10-fold results from their analysis, meaning
for a given extracellular concentration, the corresponding change
to the intracellular concentration is about 7–10-fold lower. Using
this method, changes to intracellular concentrations have been
correlated with cellular responses indirectly by observing the
effects of extracellular hydrogen peroxide perturbations [13,16].
However, since these publications appeared, other antioxidants
have been discovered as important in scavenging hydrogen per-
oxide [17]. These were not included in the original kinetic
calculations and therefore, depending on the magnitude of their
contribution, the original gradient estimate may be lower than the
actual gradient across the membrane, leading to incorrectnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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the study of cellular response to hydrogen peroxide is shifting
from using extracellular perturbation to endogenous generators,
with the reasoning that endogenous generators better mimic
physiological conditions during the action of drugs and for some
disease states in terms of the location and kinetics of peroxide
generation [12,18–20]. It is currently difﬁcult to assess the hydro-
gen peroxide concentrations generated by these endogenous tools.
To address this need, we developed a quantiﬁcation approach,
demonstrated here as we correlate fold-change in signal from a
genetically encoded peroxide sensor to change in intracellular con-
centration. HyPer, the particular probe used herein, is derived from
the OxyR transcription factor found in bacteria with YFP inserted
between two reactive thiol groups to provide a ﬂuorescent readout of
OxyR’s oxidation state [21]. The sensor is expressed by the cell and
emits a ratiometric ﬂuorescence change upon reaction with hydrogen
peroxide only; it is unresponsive to other oxidants. Unlike the read-
outs in other intracellular peroxide sensing strategies [22], the signal
of HyPer is reversible due to the activity of intracellular reductases,
and this feature allows peroxide to be monitored as a function of time.
To convert fold-change in HyPer’s signal to a change in absolute
intracellular concentration, we ﬁrst added various known amounts of
peroxide to the outside of HeLa cells expressing HyPer and measured
the resulting ﬂuorescence using methodology established in previous
work [23]. Then, we modiﬁed the compartmental model from
Antunes et al. to include peroxiredoxin, and devised methodology
for experimentally determining the kinetic parameters required for
calculation of an improved peroxide gradient across the plasma
membrane. Using the new gradient, we are able to interpret changes
in HyPer ﬂuorescence resulting from the known, external bolus
additions in terms of absolute intracellular concentration (Fig. 1a),Fig. 1. (A) Schematic of a quantiﬁcation assay for hydrogen peroxide. We measured
the gradient of hydrogen peroxide across the plasma membrane of HeLa cells and
the ﬂuorescent response of a genetically encoded sensor, HyPer, to known added
amounts of extracellular peroxide. Knowledge of the gradient provides a correla-
tion between intracellular concentration and HyPer fold change. (B) Kinetic model
of hydrogen peroxide absorption across the plasma membrane and scavenging
within the cell. A gradient is established across the plasma membrane due to the
rapid consumption of hydrogen peroxide by intracellular antioxidants. The magni-
tude of this gradient depends on the relative value of the rate constant for
intracellular consumption (kantioxidants) and the rate constant for transport across
the membrane (kintact).and the resulting calibration accomplished using extracellular addition
of peroxide can be then used to quantify peroxide produced by
intracellular generators.Results
Determining the hydrogen peroxide gradient across the HeLa
biomembrane
We determined the peroxide gradient across the HeLa bio-
membrane by adapting Antunes’ model (Fig. 1b). Since intracel-
lular concentrations of hydrogen peroxide are generally thought to
be sub-micromolar, most of the antioxidant pool is expected to
exist in the reduced form, resulting in a pseudo-ﬁrst order reaction
between hydrogen peroxide and the antioxidants [15,24,25]. Thus,
at equilibrium, the rate of absorption of hydrogen peroxide across
the plasma membrane will equal the rate of consumption of
hydrogen peroxide by the antioxidants inside the cell:
=k k[H O ] [H O ] (1)intact outside antioxidants cell2 2 2 2
where kintact is the pseudo-ﬁrst order rate constant for absorption
of peroxide across the membrane of intact cells and kantioxidants is
the sum of pseudo-ﬁrst-order rate constants for all intracellular
antioxidants. Re-arranging these terms yields an equation for the
gradient, R, across the plasma membrane
= =k
k
R
[H O ]
[H O ] (2)
outside
cell
antioxidants
intact
2 2
2 2
This gradient is independent of peroxide concentration and is
only dependent on the ﬁrst order rate constants of hydrogen
peroxide adsorption by the intact cell and by the intracellular
antioxidants.
The pseudo-ﬁrst order rate constants for the rate of adsorption of
hydrogen peroxide across the plasma membrane (kintact) and con-
sumption by antioxidants catalase (kcatalase) and glutathione perox-
idase (kGPx) in the cytoplasm were determined using methodology
similar to that outlined in [15]. To determine kintact, we tracked the
extracellular concentration of hydrogen peroxide as a function of time
using an absorbance-based horseradish peroxidase assay in place of an
oxygen electrode, and we veriﬁed the value using steady state
generation of peroxide by an extracellular glucose oxidase system
(S1). kcatalase and kGPx were determined using the experimental
protocol and data analysis methods of the original Antunes paper.
We found a kintact of 5.9 7 0.2  10-12 s1 cell1 L (N ¼ 6), kcatalase
of 8.5 7 0.3  1013 s1 cell1 L (N ¼ 8) and a kGPx 3.4 7 0.08 
1011 s1 cell1 L (N ¼ 12) (Fig. 2).
Since the time of Antunes’ widely cited gradient estimations, a
class of antioxidants called peroxiredoxins (Prx) has been hy-
pothesized to play a major role in scavenging hydrogen peroxide in
mammalian cells. Though pseudo-ﬁrst order rate constants are not
yet available in the literature, second order oxidation rate con-
stants the same order of magnitude as that of glutathione
peroxidase (GPx) have been reported for puriﬁed 2-cysteine forms
of the protein [17,26]. The 2-cysteine Prx (2-cys-Prx) that react
with peroxide are largely localized in the cytoplasm, and in HeLa
cells, cytoplasmic Prx I and II account for over 90% of these
isoforms found throughout the cell [27]. Following reaction with
peroxide, thioredoxins are responsible for returning oxidized form
of Prx to its reduced state. We believe that the contribution of this
class of antioxidants cannot be ignored in determining the
gradient across the plasma membrane.
One interesting and potentially complicating feature of 2-cys-
Prx is that the redox active thiol group can be hyper-oxidized to
sulﬁnic or sulfonic acid groups under sufﬁcient hydrogen
Fig. 2. (A) Finding kintact. The rate constant of hydrogen peroxide diffusion across the membrane was determined by adding hydrogen peroxide to a suspension of HeLa cells
and measuring the extracellular concentration of peroxide using 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) absorbance based assay. (B) Finding kcatalase.
HeLa cells were permeabilized with increasing concentrations of digitonin and lysates were incubated with 10 mM H2O2. Depletion of peroxide was measured at 240 nm
and the ﬁrst order rate constant was determined. The plateau before the rise in kinetic activity indicates conditions where the peroxisome is not disrupted. (C) Finding kGPx.
HeLa cells lysed with 0.1% Triton were incubated with 1.3–3 mM of GSH, 1.1 U/mL of glutathione reductase, 1 mM NaN3, 0.3 mM NADPH and 35 mM hydrogen peroxide.
NADPH depletion, as an indicator of hydrogen peroxide depletion, was measured at 340 nm. Hydrogen peroxide depletion kinetics between 2 and 15 mMwere then ﬁtted to
an integrated rate equation and kGPx was determined.
Fig. 3. (A) Schematic of 2-cys peroxiredoxin oxidation and reduction cycle through reactions with hydrogen peroxide and thioredoxin. Peroxide oxidizes 2-cys Prx to form
Prx-SOH. Prx-SOH can then either react with a second hydrogen peroxide to form a hyper-oxidized state, or it can interact with another Prx to form a disulﬁde bond, which
can then be reduced through the thioredoxin/thioredoxin reductase system. (B) Finding kPrx. HeLa cells lysed with 0.1% Triton were incubated with 30–50 mM yTrx, 2 mM of
yTrxR, 1 mM NaN3, 0.3 mM NADPH and 20–25 mM hydrogen peroxide. NADPH depletion, as an indicator of hydrogen peroxide depletion, was measured at 340 nm. The
kinetic data were then ﬁtted by minimizing the root mean square deviation to a simulated model of the experimental system. The rate constant kPrx was determined for
several peroxide and thioredoxin (Trx) concentrations. For the case of hydrogen peroxide ¼ 22.5 mM and Trx ¼ 30 mM, we obtained a kPrx value of 3.7  109 s1 cell1 L
(N ¼ 2). For hydrogen peroxide ¼ 22.5 mM and trx ¼ 42 mM, kPrx was 3.8  109 s1 cell1 L (N ¼ 2), and with hydrogen peroxide ¼ 25 mM and Trx ¼ 33 mM, kPrx was
3.9  109 s1 cell1 L (N ¼ 2). The kPrx value reported in the text is the average of all six trials.
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then very slowly reduced to –SOH by sulﬁredoxins (Fig. 3a) [28].
However, hyper-oxidation of 2-cys-Prx has been detected only for
cells exposed to high concentrations of extracellular hydrogen
peroxide (4 100 mM) and is generally not detected during
hydrogen peroxide mediated signaling events [25,29,30]. Belowthe hyper-oxidation detection threshold, the abundant thiore-
doxin system in most cell lines rapidly recycles any oxidized
2-cys-Prx, so we can approximate that the majority of the active
cytoplasmic 2-cys Prxs are in the reduced form [25,31]. Thus
under most in vivo hydrogen peroxide conditions, the Prx
scavenging activity can be estimated as pseudo-ﬁrst order, where
Fig. 4. Calibrating HyPer’s ratiometric ﬂuorescent response to hydrogen peroxide.
The excitation spectra of cell suspensions containing 2.5  105 cells/mL treated
with 0–7 mM hydrogen peroxide were measured at 2-min intervals with excitation
from 410–510 nm and emission monitored at 545 nm. The peak of the response
was noted. Ratiometric responses (Excitation 500 nm/420 nm) were calculated at
the peak. This ratio was divided by the baseline ratio before addition of hydrogen
peroxide, and normalized to the case where an equal amount of buffer without
hydrogen peroxide was added to obtain the normalized fold change values. The
error bars for each data point represent 95% conﬁdence intervals. In order to
determine the corresponding intracellular hydrogen peroxide concentration for
each HyPer response, the extracellular concentration is divided by 650, the
estimated gradient of hydrogen peroxide across the plasma membrane.
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constant of the oxidation step, and the total active intracellular
2-cys-Prx concentration, [Prxactive].
The reaction scheme of 2-cys Prx oxidation, hyperoxidation and
reduction is shown below:
+   − + →   − ++H O Prx (SH) H Prx (SOH) H O (3)
k
2 2 2 2
1
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Writing these reactions as ordinary differential equations yield:
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We added known initial concentrations of hydrogen peroxide
and excess puriﬁed thioredoxin/thioredoxin reductase (yTrx/
yTrxR) to reduce the 2-cys Prx present in lysates of HeLa cells,
and tracked the hydrogen peroxide depletion via NADPH con-
sumption. To determine kprx, we extracted the value of k1*[Prxactive]
from our kinetic data of peroxide concentration as a function of
time. We did so by ﬁtting the experimental kinetic data to a
simulation of the experimental system, built from the system of
ODEs above with the appropriate rate constants and known initial
conditions, with the parameter to ﬁt being the initial concentra-
tion of 2-cys-Prx in the lysate (Prxactive) (Eqs. (9)–(15), SI) [17,32–
35]. Fitting using a root-mean square deviation method, we found
a kprx of 3.8 7 0.03  109 s1 cell1 L (N ¼ 6), meaning 2-cys-
Prx scavenges peroxide 100 times faster than GPx under most
physiological conditions (Fig. 3b). As shown in Fig. S2, it is
important to consider hyper-oxidation effects for our experimental
set-up since we added a signiﬁcant peroxide bolus to cell lysate in
order to get a measurable kinetic curve.
Substituting the pseudo-ﬁrst order rate constants for intact
cells and for the various antioxidants into Eq. (2), we obtain a
gradient of 650-fold across the plasma membrane. This value issigniﬁcantly higher than the gradient of 7–10-fold calculated by
Antunes et al., and we note that the inclusion of 2-cys-Prx in our
calculations is crucial in obtaining the higher value. Typical, non-
pathogenic intracellular H2O2 perturbations have been given as
between 1 and 700 nM [36]. This widely cited information is
based on the gradient calculated by Antunes et al., combined with
data in a subsequent paper showing that a steady concentration of
less than 5 mM extracellular hydrogen peroxide does not affect
Jurkat cell morphology, but a concentration above this threshold
causes these cells to undergo apoptosis [16]. Our new gradient
suggests that the perturbation to the average intracellular con-
centration before the onset of cell death is less than 7.5 nM, and
for perturbations between 7.5 and 10.5 nM, induction of apoptosis
would be expected. Thus, changes to the level of intracellular
hydrogen peroxide that lead to the onset of apoptosis appear to be
in the low nanomolar range.
Quantifying intracellular [H2O2] with HyPer and the H2O2 membrane
gradient
With the improved membrane gradient, we now demonstrate a
quantitative approach to calibrate the HyPer sensor such that we
can translate its signal output into a change in concentration. We
made a standard curve that relates HyPer signals to extracellular
peroxide concentrations by adding known boluses of hydrogen
peroxide to a suspension of HeLa cells expressing HyPer. We
followed the kinetics of HyPer ﬂuorescence over a period of
10 min and extracted the peak ratiometric ﬂuorescence for each
bolus addition, and divided that ratio by the baseline ratiometric
ﬂuorescence to obtain a fold-change in HyPer response. To account
for potential pH effects, buffer without hydrogen peroxide was
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every hydrogen peroxide bolus is normalized to this control case.
The intracellular sensor responded dynamically to 2–7 mM of
hydrogen peroxide added externally to a suspension containing
2.5  105 cells/mL (Fig. 4). Using our experimentally determined
hydrogen peroxide gradient, we can calculate the corresponding
intracellular peroxide change for each different external hydrogen
peroxide concentration added. This analysis suggests HyPer re-
sponds to 3–10 nM changes in intracellular peroxide concentra-
tions (Fig. 4). Now, independent of the method of hydrogen
peroxide perturbation, we can measure the intracellular fold-
change in HyPer signal and use the standard curve in Fig. 4 to
determine the change in terms of an absolute concentration.Discussion
Peroxiredoxins have been proposed as the dominant hydrogen
peroxide elimination enzyme in mammalian cells, and our experi-
mental results support this hypothesis as we found that the
pseudo-ﬁrst-order rate constant for the oxidation of Prx by
hydrogen peroxide is about 100 times faster than that of GPx.
This ﬁnding suggests that antioxidant-based therapeutics should
focus on targeting Prx isoforms and their reduction partners,
thioredoxin and glutathione. Another implication of peroxiredoxin
activity is the much higher hydrogen peroxide gradient we
measured across the plasma membrane. The new gradient esti-
mates the switch between non-pathological to pathological per-
turbations to the intracellular concentration of peroxide to be in
the low nanomolar range. This lower intracellular concentration
means that the rate of cytoplasmic hydrogen peroxide reacting
with a protein thiol is even slower than previously thought. Direct
action of hydrogen peroxide on its target may require very close
proximity of the target to the source of generation, as suggested by
the ﬂood-gate model [26,30,37]. Another possibility is that hydro-
gen peroxide acts on the downstream signaling targets in an
indirect manner, through oxidation of more abundant Prx/Gpx
antioxidants or conversion to a more reactive radical species such
as hydroxyl radical [1,29,38]. Improving our quantitative under-
standing of these concentration parameters can establish more
powerful mathematical models of biological redox systems. Spe-
ciﬁcally, knowledge of actual intracellular concentrations is im-
portant for allowing evaluation of the likelihood of mass–action
interactions of various oxidants with their supposed targets,
yielding better predictions of fundamental redox processes.
Furthermore, concentrations associated with phenotypic re-
sponses establish design criteria for future ROS-therapeutics as
to how much of a perturbation to the intracellular hydrogen
peroxide level is needed to switch from proliferation to cell death
[6,7].
Our calibration of an intracellular peroxide sensor using a
gradient measurement is an important advance that supports
and parallels the development of physiologically relevant intra-
cellular ROS-generators. The gradient can be used for intracellular
quantiﬁcation with a known amount of exogenous addition, but it
alone cannot give any concentration information for intracellular
generator tools. For this task, an intracellular sensor must be
paired with knowledge of the gradient. As Fig. 4 indicates, the
response of HyPer to hydrogen peroxide, like that of many popular
redox sensors, is non-linear [22]. As a result, it is difﬁcult to
interpret the common approach of reporting sensor signal as fold-
change, since an increase in signal between a 1.5 -fold change
and a 2 -fold change, versus a 2 -fold change and a 2.5 -fold
change are not necessary the same. The calibration approach
detailed herein will be important in providing real-timeveriﬁcation, visualization and quantiﬁcation of the perturbations
produced by intracellular peroxide generators.
Accuracy in measuring perturbations to the intracellular per-
oxide concentration depends in part on the choice of sensor. We
chose HyPer to demonstrate our quantiﬁcation approach because
it is an intracellular sensor speciﬁc for peroxide, and it is reversible
and ratio-metric [23]. These characteristics offer an advantage
over the dye-based sensors such as DCFH or PG-1 since HyPer
measures real-time concentrations rather than a cumulative effect
[39], and HyPer provides greater speciﬁcity and sensitivity than
other ﬂuorescent genetically-encoded sensors such as roGFP [40].
However, using the sensor is not without its caveats. First, the
probe is pH sensitive, so proper controls are required to ensure the
results are not artifacts of the external environment [41]. We
addressed this issue by including a control where buffer without
hydrogen peroxide was added to a suspension of HeLa cells, and
fold-change for every hydrogen peroxide bolus was normalized to
this control case. Secondly, the OxyR domain has a second order
rate constant of 105 M1 s1 with hydrogen peroxide [42], while
2-cys Prx interacts with hydrogen peroxide with a second order
rate constant of 107 M1 s1. Thus, in the kinetic competition for
reaction with intracellular peroxide, HyPer does not effectively
compete with Prx. It follows that in lining up our standard curve
with the results of the biochemical gradient measurement, we are
slightly over-estimating the intracellular concentration of hydro-
gen peroxide for each HyPer fold-change. We should note that our
quantitative approach generalizes to probes other than HyPer, and
accuracy and responsive regions will improve as improved hydro-
gen peroxide sensors are developed.
The accuracy of this quantiﬁcation is also dependent on the
accuracy of the gradient across the plasma membrane. In ﬁtting
our kinetic data for cytoplasmic 2-cys-Prx activity in HeLa cells,
where Prx I and II are predominant, we were able to obtain second
order rate constants for Prx II but not for Prx I for use in our
numerical model. Thus, our experimental data is an average
activity of both Prx isoforms in the cytoplasm, but our theoretical
ﬁt assumes Prx I have the same rate constants as Prx II. It has been
observed that Prx I is less susceptible to hyper-oxidation than Prx
II, and is rather inactivated by phosphorylation, however these
kinetic rates are unknown and so could not be included in our
model [30]. In addition, a recent kinetic model suggests the
inclusion of an inhibitor of Prx II as a plausible way to obtain the
correct oxidation/reduction kinetics for the antioxidant in red
blood cells, and this modeling approach predicts that only a small
fraction of the total Prx II protein is active in these cells [43]. Since
our kinetic experiments are done under dilute, lysed cell condi-
tions, it is possible that any inhibitor function may be disrupted
under these experimental conditions and we over-estimate the
concentration of active Prx II. The identity of molecular species
that may act as inhibitors and whether this theory applies in HeLa
cells remain open questions. Finally, discovery of new antioxidants
and targets that react with hydrogen peroxide at a rate similar to
that of Prx would further increase the value of the gradient. The
model and analysis can easily be updated as more information
becomes available. It should be noted that the current calculation
as it stands is already a vast improvement over the previous
gradient measurement. A combined effort of intracellular quanti-
ﬁcation and generation tools will allow physiologically relevant
and systematic studies of the role of hydrogen peroxide in
determining cellular phenotypes. In addition to promoting funda-
mental, mechanistic understanding of human redox biology, such
studies hold promise for determining quantitative design criteria
for future ROS-based therapeutics.
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Materials
Hydrogen peroxide, horseradish peroxidase (HRP), neomycin,
penicillin–streptomycin, glucose oxidase, catalase, L-glutathione,
glutathione reductase, digitonin, triton X-100, were purchased
from Sigma (St. Louis, MS, USA). 2,2′-Azino-bis(3-ethylbenzothia-
zoline-6-sulfonic acid) diammonium salt (ABTS) was purchased
from Tokyo Chemical Industry Co (Portland, OR, USA). D(þ)-Glu-
cose was purchased from Macron Fine Chemicals (Center Valley,
PA, USA). NADPH was purchased from Roche (Basel, Switzerland).
HeLa cells were a gift from the Wittrup Lab at MIT (Cambridge,
MA, USA). The Modiﬁed Eagle’s medium (EMEM) and fetal bovine
serum were purchased from ATCC (Manassas, VA, USA). Trypsin
was purchased from Lonza (Walkerville, MD, USA). Lipofectamine
2000 was purchased from Invitrogen (Carlsbad, CA, USA). A
plasmid encoding HyPer-cyto plasmid was purchased from Evro-
gen (Moscow, Russia). Q HP FF, Phenyl HP and Superdex75 FPLC
puriﬁcation columns were purchased from GE Healthcare (Fair-
ﬁeld, CT, USA). Other common chemicals to make buffer solutions
were purchased from VWR International (USA).
Cell culture and transfection
HeLa cells were cultured in EMEM with 10% FBS at 37 °C, 95%
air and 5% CO2. A stable cell line of HeLa cells expressing HyPer
was created by transfecting HeLa cells with a mixture of plasmid
DNA and Lipofectamine for 24 h, and a single colony was gradu-
ally selected over a period of 6 weeks using neomycin at 1 mg/mL.
The plasmid was maintained in the cell with neomycin at
0.2 mg/mL.
Fluorescence spectroscopy for HyPer readings in intact HeLa cells
HeLa cells expressing HyPer were trypsinized, washed once in
phosphate buffer saline (PBS), pH 7.4 and re-suspended in the
same buffer at a concentration of 250,000 cells/mL. Excitation
spectra of HyPer expressed in cells were recorded using a Tecan
M200 microplate reader with excitation at 410–510 nm, 9 nm
bandwidth, and emission at 545 nm, 20 nm bandwidth. A base-
line excitation spectrum was taken, then a bolus of hydrogen
peroxide was added to the suspension and kinetics were followed
for a period of 10 min. HyPer’s ratiometric ﬂuorescent response
was obtained by dividing the emission reading for excitation at
500 nm by the emission reading for excitation at 420 nm, then
dividing the peak of the ratiometric ﬂuorescence by the baseline to
obtain a fold change. The fold change data is normalized to a
control case where no hydrogen peroxide was added to the system
(i.e. an equal volume of buffer only was added).
Consumption of hydrogen peroxide by intact HeLa cells
HeLa cells containing HyPer were grown in 10 cm BD Falcon
dishes (VWR International, USA) until conﬂuent. The cells were
trypsinized, washed once in PBS, pH 7.4, and re-suspended in PBS
with 2 g/L D-glucose at a concentration of 106 cells/mL, 10 mL
total. A bolus of hydrogen peroxide was then mixed into the dish,
making it a total of 80–100 mM in cell suspension. Every 2 min, a
200 mL sample of the cell suspension was inactivated with 13 mL
5 N HCl to prevent further antioxidant scavenging. The samples
were incubated for 10 min in HCl, then centrifuged at 14,000g.
160 mL of the supernatant was removed, mixed with 70 mL of 1 M
Kpi (pH 8.0), followed by 50 mL of 2.5 mM of 2,2′-azino-bis(3-
ethylbenzothiazoline-6-sulfonic acid) (ABTS) solution and 10 mL of
3 mg/mL horse-radish peroxidase. The samples were read at anabsorbance wavelength of 405 nm. A standard curve between
0 and 50 mM for hydrogen peroxide was done with each set of
data.Exposure of HeLa cells to steady state levels of hydrogen peroxide
If the ﬁrst order rate constant of hydrogen peroxide consump-
tion by intact HeLa cells is correct, then we can do a steady state
balance between the consumption of hydrogen peroxide and the
generation of hydrogen peroxide by a glucose oxidase system [13].
Glucose oxidase was diluted in PBS (pH 7.4) with 2 g/L D(þ)-glu-
cose to concentrations of 5 mU/mL. The rate of hydrogen
peroxide generation for the diluted stock was determined using
the ABTS assay. Then, 10 mM of hydrogen peroxide mixed with
0.8 million cells/mL and an appropriate amount of glucose oxidase
(generates 2.8 mM hydrogen peroxide/min) in the PBS þ glucose
solution, and the concentration of hydrogen peroxide outside the
cell was measured for a period of 60 min using the ABTS assay.Consumption of hydrogen peroxide by catalase
Trypsinized HeLa cells expressing HyPer (106 cells/mL) were
lysed by re-suspending the cells in 50 mM potassium phosphate
buffer (pH 7.4) containing digitonin. Digitonin concentration was
varied from 0.01 to 1 mg/mL. For each lysate sample, hydrogen
peroxide depletion was measured in the presence of 10 mM
hydrogen peroxide and kinetics were followed at 37 °C for
5 min at 240 nm (extinction coefﬁcient 43.6 M1 cm1). At
digitonin concentrations of less 0.1 mg/mL, only the plasma
membrane was affected, yielding depletion kinetics due to catalase
acting on H2O2 that diffused across an intact peroxisomal
membrane.Consumption of hydrogen peroxide by glutathione peroxidase
HyPer HeLa cells expressing HyPer (5 million cells/mL) were
lysed in 50 mM potassium phosphate (pH 7.4), 1 mM DPTA buffer
containing 0.1% Triton solution. The lysate mixture was then pre-
incubated at 37 °C with a range of 1–3 mM of GSH, 1.1 U/mL
glutathione reductase, 0.3 mM NADPH and 1 mM NaN3 to reduce
any oxidized GPx for 10 min. Then, a bolus of 35 mM hydrogen
peroxide was added to the mixture and NADPH depletion at
340 nm (extinction coefﬁcient 6.22 mM1 cm1) was followed
for a period of 5 min. For kinetic analysis, the part of the curve
corresponding to 2–15 mM hydrogen peroxide remaining was
used for ﬁtting to the integrated rate equation shown below:
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where t is the time since the addition of a bolus of hydrogen
peroxide to the lysate system, k1′, k2′, k3′ are rate constants
associated with GPx redox reaction as indicated in SI, and [GPx]total
is the total concentration of GPx enzyme. kGpx ¼ k1′*[GPx]total and
was obtained by the inverse slope of linear ﬁtting
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HeLa cells expressing HyPer (5.8 million/mL) were lysed in
20 mM Hepes (pH 7.4), 1 mM EDTA buffer containing 0.1% Triton
solution. The lysate mixture was pre-incubated at 37 °C with a
range of 20–50 mM yeast Trx, 2 mM yeast TrxR, 0.4 mM NADPH
and 1 mM NaN3 for a period of 10 min. Then, a bolus of hydrogen
peroxide between 20 and 25 mM was added to the mixture and
NADPH depletion was followed by monitoring absorbance at
340 nm (extinction coefﬁcient 6.22 mM1 cm1) for a period
of 5 min. For kinetic analysis, the experimental data was ﬁtted to a
model simulation using root-mean square deviation and the
pseudo-ﬁrst order rate constant kprx was extracted.
Puriﬁcation of yeast-thioredoxin and thioredoxin-reductase
Plasmids for yeast Trx/TrxR (pET17b-yTrx1 and pET17b-yTrxR)
were a gift from Dr. Sang Won Kang (Ewha Womans University,
Seoul, Korea) [32]. To purify the recombinant proteins, Escherichia
coli BL21 (DE3) transformed with the plasmids were was grown
until OD 0.6 (λ ¼ 600 nm) in 250 mL of Terriﬁc Broth, at which
point expression was induced by addition of 1 mM isopropyl-1-
thio-B-D-galatoside (IPTG), cells are harvest after shaking for 4 h
at 250 rpm. The cells are lysed, on ice, for 20 min, 1 min interval
in 10 mL of buffers speciﬁed in [32], then spun at 12,000g for
15 min. The supernatant was ﬁltered through a 0.22 mm Acrodisc
Syringe Filter (Pall Corporation, USA). For TrxR, the crude extract
was loaded onto a Q HP fast-ﬂow anionic exchange FPLC column.
The protein was eluted with a linear gradient of 0–500 mM NaCl
in 20 mM Tris–HCl (pH 7.5), and the fraction containing yTrxR
protein was veriﬁed through SDS-PAGE gel and used for a
subsequent puriﬁcation. After dialyzing the fraction against
20 mM Hepes-NaOH (pH 7.0), the protein was equilibrated with
1 M ammonium sulfate (pH 7.0) and loaded onto a Phenyl HP FPLC
column. The protein of interest came out in the ﬂow-through
before the elution step, and the pool of puriﬁed proteins were
dialyzed against buffer containing 20 mM Hepes (pH 7.4) and
stored at 70 °C until required. For Trx, the crude extract was
heat-treated for 30 min at 75 °C and centrifuged to remove
denatured protein. The soluble supernatant was loaded onto the
Q-HP fast ﬂow anionic exchange and eluted with the same linear
NaCl gradient as TrxR. The fractions containing Trx were then
loaded onto Superdex 75 gel ﬁltration column equilibrated with
20 mM Tris–HCl, 1 mM EDTA and 150 mM NaCl (pH 7.0). Protein
purities for both Trx/TrxR were conﬁrmed through SDS-Page gel
and UV spectra (S3). The reducing potential of yTrxR was mea-
sured by pre-oxidizing yTrx with equimolar hydrogen peroxide for
10 min, then incubating with yTrxR and NADPH to measure the
reduction kinetics [32]. An activity of 2.4 7 0.3 mmol/min/mg was
found, indicating active yTrxR was produced that couples with the
yTrx redox state.
Statistical analysis
For kinetics analyses at least three technical replicates and two
biological replicates were performed for each rate constant. The
experimental values are reported as the mean 7 standard error of
mean (SEM). For the HyPer standard curve, the data points
represent the mean over 4 trials (2 technical and 2 biological
replicates), and the error bars are the 95% conﬁdence intervals.
To determine kprx, a parameter sweep from 0.1 to 100, step size
0.1 was performed using Matlab2013, and for each value of kprx,
the root mean square deviation (RMSD) is calculated between the
simulation kinetic curve and the experimental kinetic curve. The
kprx value that gives the minimum of the RMSD function is the
estimated kprx. This ﬁtting was performed for various Trx andhydrogen peroxide concentrations, and the overall kprx reported is
the mean from all of the ﬁttings
=
∑ −x x
n
RMSD
( )
(17)
n s e
1
2
where n is the number of data points, xs is the value of the
simulation data, and xe is the value of the experimental data.Conﬂicts of interest
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